Steven C. Quay, M.D., Ph. D.

Steven C. Quay, M.D., Ph. D.

atAtossa Therapeutics· In proxies 2022–2024

Pay in FY2024+17% from the year before · Atossa Therapeutics stock +7.3% the same year

Steven C. Quay, M.D., Ph. D. was paid $2.8M in FY2024 (Dec), up 17%. Atossa Therapeutics stock rose 7.3% that year.

Pay$100 in the stock at the end of FY21 → $59
Pay is from the Summary Compensation Table of each Atossa Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Atossa TherapeuticsPublic company · 4 yr
    • 2022 – Present · 4 yrStock in role -91%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?